HIV-1 Clade B and C Isolates Exhibit Differential Replication: Relevance to Macrophage-Mediated Neurotoxicity
Authors:
- 19 February 2011
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 20 (3) , 277-288
Abstract
HIV-associated neurocognitive disorders (HAND) continue to be a consequence of HIV-1 infection among clade B-infected individuals. In contrast, the incidence of severe neurological impairment is lower among clade C-infected patients in regions of Sub-Saharan Africa and India. Biological aspects such as replication, cytopathicity, inflammatory response, and neurotoxicity unique to each clade influence neuropathogenicity and ultimately affect the clinical outcome of the disease. We hypothesize that productive infection by clade C isolates leads to macrophage-mediated neurotoxicity, although to a lesser extent than clade B isolates. Using a panel of primary isolates of clades B and C we demonstrated that clade B has higher replication efficiency in monocyte-derived macrophages (MDM) through reverse transcriptase activity assay and HIV-1 p24 antigen ELISA. To test the neurotoxicity of clades B and C, we used an in vitro neurotoxicity model. Conditioned medium from clade B-infected MDM was neurotoxic to rat and human neuron cultures. In contrast, clade C isolates mediated neurotoxicity when a higher initial viral titer was used for MDM infection. Furthermore, neurotoxicity mediated by isolates of both clades correlated with virus replication in MDM. Together, these results suggest that in comparison to clade B, primary isolates of clade C have slower replication kinetics in primary MDM, leading to lower levels of macrophage-mediated neurotoxicity. Elucidating the differences in replication and macrophage-mediated neurotoxicity between isolates of HIV-1 clades B and C will provide important insights needed to clarify the disparity seen in HAND incidence.Keywords
This publication has 45 references indexed in Scilit:
- CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the EpidemicJournal of Virology, 2009
- NMDA Receptor Activation by HIV-Tat Protein Is Clade DependentJournal of Neuroscience, 2008
- Genotypic Characterization and Comparison of Full-Length Envelope Glycoproteins from South African HIV Type 1 Subtype C Primary Isolates That Utilize CCR5 and/or CXCR4AIDS Research and Human Retroviruses, 2008
- Clade‐specific differences in neurotoxicity of human immunodeficiency virus‐1 B and C Tat of human neurons: significance of dicysteine C30C31 motifAnnals of Neurology, 2008
- Human Immunodeficiency Virus Type 1 Subtype C Tat Fails To Induce Intracellular Calcium Flux and Induces Reduced Tumor Necrosis Factor Production from MonocytesJournal of Virology, 2007
- The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementiaProceedings of the National Academy of Sciences, 2006
- The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infectionAIDS, 2006
- Infectivity and Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1 Variants Isolated during Primary InfectionJournal of Virology, 2003
- Adaptive Changes after Human Immunodeficiency Virus Type 1 TransmissionAIDS Research and Human Retroviruses, 2002
- CCR5 and CXCR4 Usage by Non-Clade B Human Immunodeficiency Virus Type 1 Primary IsolatesJournal of Virology, 2002